Diabetes: Therapy for gestational diabetes mellitus--time for a change?
Research output: Contribution to journal › Journal article › Research › peer-review
For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.
| Original language | English |
|---|---|
| Journal | Nature Reviews Endocrinology |
| Volume | 11 |
| Issue number | 6 |
| Pages (from-to) | 327-8 |
| Number of pages | 2 |
| ISSN | 1759-5029 |
| DOIs | |
| Publication status | Published - Jun 2015 |
- Diabetes, Gestational, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy
Research areas
ID: 154136837